# Translational Neural Devices (U44 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-ns-21-022-translational-neural-devices-u44-clinical-trial-optional/  
Official notice: https://www.grants.gov/search-results-detail/333155

> National Institutes of Health offered grants of up to $1.0 million to small businesses. It expected to make $4.0 million in total. Applications closed on December 20, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-NS-21-022 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | December 20, 2022 |
| Award ceiling | $1.0 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | $4.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.853 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical study to collect safety and effectiveness data required to support a marketing application or to inform final device design.

## Questions people ask

### Is RFA-NS-21-022 still open?

No. It closed on December 20, 2022.

### Who can apply for Translational Neural Devices (U44 Clinical Trial Optional)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Translational Neural Devices (U44 Clinical Trial Optional)?

Closed December 20, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.0 million each. About $4.0 million in total.

### Who has been funded under RFA-NS-21-022?

NIH RePORTER lists 3 projects funded under RFA-NS-21-022 in fiscal 2022 to 2026, at 3 institutions. The most were at Rehabtek, LLC, Auxilium Biotechnologies Inc., Mitovation, Inc.

### Who has won Extramural Research Programs in the Neurosciences and Neurological Disorders grants before?

The largest recipients over five fiscal years were The General Hospital Corporation, The Regents of the University of California, San Francisco, The Johns Hopkins University. The program made 8,641 awards worth $9.1 billion in that time.